GLOBAL RISEDRONATE MARKET 2019 BY MANUFACTURERS, REGIONS, TYPE AND APPLICATION, FORECAST TO 2024

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Risedronate is in a class of drugs called bisphosphonates used for the treatment of Paget's disease of bone (in which the formation of bone is abnormal) and in persons with osteoporosis (in which the density and strength of bones are reduced).

Scope of the Report:
The worldwide market for Risedronate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Risedronate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
- Merck
- Amgen
- Teva
- Mylan
- Apotex
- Sanofi
- Abbott
- Novartis
- Tecoland
- Taj Pharmaceuticals

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- 5 mg Tablets
- 35 mg Tablets
- 75 mg Tablets
- 150 mg Tablets

Market Segment by Applications, can be divided into
- Postmenopausal Osteoporosis
- Men with Osteoporosis

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Risedronate product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Risedronate, with price, sales, revenue and global market share of Risedronate in 2017 and 2018.
Chapter 3, the Risedronate competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Risedronate breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Risedronate market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Risedronate sales channel, distributors, customers, research findings and conclusion, appendix and data source.